Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as respiratory syncytial virus, respiratory medical need in pediatrics, and rhinovirus. The company employs synthetic biology and reverses genetics to recode specific RSV genes using targeted human codon deoptimization.